+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 65Years
All Genders
ID06300203

Evaluation of a Humanized Antibody Targeting IL-4 Receptor Alpha in Adults With Uncontrolled Seasonal Allergic Rhinitis Under Standard Treatment

Led by Beijing Tongren Hospital · Updated on 2025-09-25

120

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Seasonal allergic rhinitis AR is a common chronic nasal condition caused by an overreaction to allergens such as pollen, leading to symptoms like sneezing, a runny nose, itching, and nasal congestion. This condition often affects quality of life by causing fatigue and difficulty concentrating, and it may be linked with asthma in many patients. The study aims to evaluate a humanized antibody targeting the interleukin-4 receptor alpha subunit in people with uncontrolled seasonal allergic rhinitis who are already receiving standard treatment. Participants in this randomized, double-blind, placebo-controlled Phase 2 study will receive either a subcutaneous injection of the interleukin-4 receptor antibody or a placebo injection. The study will compare these treatments in their effect on symptoms of seasonal allergic rhinitis. The treatment period lasts up to 2 weeks, with ongoing monitoring to assess changes in nasal symptoms. Throughout the study, participants will report their nasal symptoms daily, focusing on changes from their baseline condition. Researchers will measure the average change in total nasal symptom scores by week 2 to evaluate the treatments effects. The study includes safety monitoring and requires participants to provide informed consent. Total participant involvement spans the treatment and observation periods, ensuring thorough assessment of efficacy and safety.

CONDITIONS

Brief Title

Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis

Research Team

L

Luo Zhang

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here